WorldChinaJapanIndiaSouth KoreaIndonesiaTaiwanThailandU.S.East AsiaChinaHong KongMacaoTaiwanMongoliaJapanSouth KoreaNorth KoreaSoutheast AsiaIndonesiaThailandMalaysiaSingaporePhilippinesVietnamMyanmarCambodiaLaosBruneiEast TimorSouth AsiaIndiaPakistanAfghanistanBangladeshSri LankaNepalBhutanMaldivesCentral AsiaKazakhstanUzbekistanTurkmenistanTajikistanKyrgyzstanOceaniaAustraliaNew ZealandPapua New GuineaPacific IslandsRest of the WorldMiddle EastRussia & CaucasusNorth AmericaLatin AmericaEuropeAfricaTrendingIran tensionsInflationTrump administrationArtificial intelligenceElectric vehiclesSupply ChainTaiwan tensionsBank of JapanImmigrationESGExplainerBusinessBusinessSemiconductorsAutomobilesEnergyTransportationRetailTravel & LeisureMedia & EntertainmentFood & BeverageFinanceElectronicsStartupsBusiness dealsMarketsMarketsEquitiesCurrenciesBondsCommoditiesPropertyIPOWealth ManagementTechTech#techAsiaChina techStartupsCryptocurrenciesDealStreetAsiaPoliticsPoliticsChinaJapanIndiaSouth KoreaIndonesiaTaiwanThailandU.S.East AsiaChinaHong KongMacaoTaiwanMongoliaJapanSouth KoreaNorth KoreaSoutheast AsiaIndonesiaThailandMalaysiaSingaporePhilippinesVietnamMyanmarCambodiaLaosBruneiEast TimorSouth AsiaIndiaPakistanAfghanistanBangladeshSri LankaNepalBhutanMaldivesCentral AsiaKazakhstanUzbekistanTurkmenistanTajikistanKyrgyzstanOceaniaAustraliaNew ZealandPapua New GuineaPacific IslandsRest of the WorldMiddle EastRussia & CaucasusNorth AmericaLatin AmericaEuropeAfricaEconomyEconomyChinaJapanIndiaSouth KoreaIndonesiaTaiwanThailandU.S.East AsiaChinaHong KongMacaoTaiwanMongoliaJapanSouth KoreaNorth KoreaSoutheast AsiaIndonesiaThailandMalaysiaSingaporePhilippinesVietnamMyanmarCambodiaLaosBruneiEast TimorSouth AsiaIndiaPakistanAfghanistanBangladeshSri LankaNepalBhutanMaldivesCentral AsiaKazakhstanUzbekistanTurkmenistanTajikistanKyrgyzstanOceaniaAustraliaNew ZealandPapua New GuineaPacific IslandsRest of the WorldMiddle EastRussia & CaucasusNorth AmericaLatin AmericaEuropeAfricaFeaturesTrading AsiaASEAN MoneyTech AsiaBusiness AsiaChina Up ClosePolicy AsiaBig in AsiaDatawatchInfographicsOpinionOpinionEditor-in-Chief's PicksThe Nikkei ViewLife & ArtsLife & ArtsLifeArtsMy Personal HistoryTea LeavesEat & DrinkDestinationsBooksObituariesWatch & ListenPodcastsVideoPhotosCompaniesPharmaceutical maker to add temperature controls, bolstering supply chainEisai plans to invest the rough equivalent of $64 million at this facility in Hatfield, England. (Eisai)MAYUKO SUZUKIJune 16, 2026 05:10 JSTTOKYO -- Japanese drugmaker Eisai said Monday that it will invest roughly 48 million pounds ($64 million) in new packaging facilities at a U.K. plant for added flexibility in production and supply.Read NextLatest on CompaniesSponsored ContentAbout Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.
Japan's Eisai to pump $64m into UK plant to package injectable drugs
Pharmaceutical maker to add temperature controls, bolstering supply chain
181 words~1 min read







